BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)
CUSIP: 088786108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
- Shares outstanding
- 50,340,741
- Total 13F shares
- 39,722,044
- Share change
- +9,254,434
- Total reported value
- $803,959,492
- Put/Call ratio
- 365%
- Price per share
- $20.24
- Number of holders
- 105
- Value change
- +$167,237,644
- Number of buys
- 59
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
9.8%
|
4,942,823
|
$123,076,293 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
6.9%
|
3,490,506
|
$86,913,599 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
6.4%
|
3,246,759
|
$80,844,299 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.3%
|
1,672,000
|
$41,632,800 | — | 31 Mar 2024 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.1%
|
1,545,026
|
$38,471,148 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3%
|
1,516,715
|
$37,766,203 | — | 31 Mar 2024 | |
| Kate Bingham |
3/4/5
|
Director |
—
class O/S missing
|
1,870,379
|
$32,731,633 | — | 13 Jul 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.4%
|
1,193,051
|
$29,706,970 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.1%
|
1,038,917
|
$25,869,033 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,004,535
|
$25,012,922 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
914,476
|
$22,770,452 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.8%
|
889,258
|
$22,142,524 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.8%
|
883,105
|
$21,989,000 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.6%
|
800,000
|
$19,920,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
575,030
|
$14,318,247 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
1.1%
|
554,163
|
$13,798,659 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1%
|
524,253
|
$13,053,900 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
0.89%
|
450,000
|
$11,205,000 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.84%
|
420,800
|
$10,477,920 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.8%
|
401,646
|
$10,001,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.79%
|
396,812
|
$9,880,620 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.68%
|
342,594
|
$8,530,591 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.68%
|
340,866
|
$8,487,563 | — | 31 Mar 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.66%
|
333,001
|
$8,291,725 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
252,172
|
$6,279,083 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
0.41%
|
205,423
|
$5,115,033 | — | 31 Mar 2024 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.38%
|
190,200
|
$4,736,000 | — | 31 Mar 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.36%
|
179,800
|
$4,477,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
165,700
|
$4,126,000 | — | 31 Mar 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.31%
|
158,293
|
$3,941,496 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.3%
|
153,000
|
$3,809,700 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
136,775
|
$3,405,698 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
133,068
|
$3,308,071 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
122,200
|
$3,042,780 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.18%
|
92,552
|
$2,304,545 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.17%
|
84,980
|
$2,116,002 | — | 31 Mar 2024 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.16%
|
80,090
|
$1,994,241 | — | 31 Mar 2024 | |
| COMERICA BANK |
13F
|
Company |
0.16%
|
78,770
|
$1,961,373 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.12%
|
60,000
|
$1,494,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
59,440
|
$1,480,056 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
55,450
|
$1,380,705 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.11%
|
54,986
|
$1,369,151 | — | 31 Mar 2024 | |
| L & S Advisors Inc |
13F
|
Company |
0.1%
|
50,260
|
$1,251,474 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
46,600
|
$1,160,340 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.1%
|
48,700
|
$1,114,743 | — | 31 Mar 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.09%
|
43,480
|
$1,083,000 | — | 31 Mar 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.08%
|
42,729
|
$1,063,525 | — | 31 Mar 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.07%
|
34,879
|
$868,487 | — | 31 Mar 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.06%
|
30,600
|
$761,940 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
28,585
|
$711,766 | — | 31 Mar 2024 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) as of Q2 2024
As of 30 Jun 2024,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,722,044 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, First Light Asset Management, LLC, MORGAN STANLEY, and Fairmount Funds Management LLC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
93
Q2 2024 holders
105
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.